Disseminated BCG disease and recurrent pulmonary infections in a child with trisomy 21 carrying a novel BACH2 variant of uncertain significance: a 5-year case report.
- 1Pediatric Pulmonology Division, Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
- 2Neonatology Division, Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
- 3Department of Parasitology, Noguchi Memorial Institute for Medical Research, Accra, Ghana.
Abstract
Background
Trisomy 21 is associated with combined immune dysregulation, including lymphopenia, impaired responses to vaccines, and heightened susceptibility to respiratory infections, driven in part by triplication of chromosome 21-encoded interferon receptor genes. BACH2 haploinsufficiency is a rare monogenic immunodeficiency characterized by lymphopenia, hypogammaglobulinemia, and susceptibility to infections and autoimmune diseases. Co-occurrence of these two conditions has not been previously described.Case presentation
We report a 5-year longitudinal course in a Kenyan girl with trisomy 21, congenital heart disease, aspiration, and severe gastroesophageal reflux disease (GERD) found via whole exome sequencing to carry a heterozygous BACH2 missense variant (c.1420C > G;p.Leu474Val) of uncertain significance; parental segregation remains incomplete. In silico protein structural modeling (FoldX and Missense3D) yielded discordant predictions of the variant's effect on the protein's stability and structure. Additional in silico pathogenicity predictions were also inconsistent: Sorting Intolerant from Tolerant (SIFT), Evolutionary Model of Variant Effect (EVE), PolyPhen-2, and CADD Phred scores predicted pathogenicity, while REVEL and AlphaMissense suggested a lack of deleteriousness. Persistent panlymphopenia and profoundly low IgM levels were documented throughout the follow-up period. Over these 5 years, the girl sustained six hospitalized lower respiratory tract infections (LRTIs), with four requiring intensive care, which were disseminated Bacille Calmette-Guérin (BCG) disease, respiratory syncytial virus and SARS-CoV-2 infections, and influenza A(H1N1)pdm09 pneumonia. Chest computed tomography at 4 years showed bilateral consolidations without bronchiectasis. Annual autoimmune screening remained negative.Conclusion
This case illustrates the burden caused by severe and diverse respiratory pathogenic infections in a child with trisomy 21 and a candidate BACH2 variant. Trisomy 21 alone plausibly explains much of the phenotype; an independent contribution from the BACH2 variant remains unproven pending functional and segregation studies. Clinical considerations supported by this case include the potential value of prevaccination immunological screening to prevent BCG disease, equitable access to viral prophylaxis, and early specialist engagement in refractory cases.
Related
- Points to consider for the reporting of variants of uncertain significance in germline genetic and genomic testing: A statement of the American College of Medical Genetics and Genomics (ACMG)
- Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign.
- Cockayne Syndrome Phenotype in a Sudanese Child With a Homozygous ERCC8 Splice-Site Variant of Uncertain Significance: A Case Report
- A translational pipeline for classification of variants of uncertain significance to support gene therapy clinical trial in OTOF-related deafness
- Case Report: ABCC8 variants in Chinese youth: a nine-family case series and a pragmatic three-pillar framework for adjudicating variants of uncertain significance
BibTeX
@article{maranguboore2026disseminated,
title = {{Disseminated BCG disease and recurrent pulmonary infections in a child with trisomy 21 carrying a novel BACH2 variant of uncertain significance: a 5-year case report.}},
author = {Diana Marangu-Boore and Brian Maugo and Rita Afriye Boateng},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1934925},
url = {https://europepmc.org/article/MED/42898127},
note = {CC BY},
}
RIS
TY - JOUR
TI - Disseminated BCG disease and recurrent pulmonary infections in a child with trisomy 21 carrying a novel BACH2 variant of uncertain significance: a 5-year case report.
AU - Diana Marangu-Boore
AU - Brian Maugo
AU - Rita Afriye Boateng
PY - 2026
DA - 2026/10/05
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1934925
UR - https://europepmc.org/article/MED/42898127
AB - Background Trisomy 21 is associated with combined immune dysregulation, including lymphopenia, impaired responses to vaccines, and heightened susceptibility to respiratory infections, driven in part by triplication of chromosome 21-encoded interferon receptor genes. BACH2 haploinsufficiency is a rare monogenic immunodeficiency characterized by lymphopenia, hypogammaglobulinemia, and susceptibility to infections and autoimmune diseases. Co-occurrence of these two conditions has not been previously described.Case presentation We report a 5-year longitudinal course in a Kenyan girl with trisomy 21, congenital heart disease, aspiration, and severe gastroesophageal reflux disease (GERD) found via whole exome sequencing to carry a heterozygous BACH2 missense variant (c.1420C > G;p.Leu474Val) of uncertain significance; parental segregation remains incomplete. In silico protein structural modeling (FoldX and Missense3D) yielded discordant predictions of the variant's effect on the protein's stability and structure. Additional in silico pathogenicity predictions were also inconsistent: Sorting Intolerant from Tolerant (SIFT), Evolutionary Model of Variant Effect (EVE), PolyPhen-2, and CADD Phred scores predicted pathogenicity, while REVEL and AlphaMissense suggested a lack of deleteriousness. Persistent panlymphopenia and profoundly low IgM levels were documented throughout the follow-up period. Over these 5 years, the girl sustained six hospitalized lower respiratory tract infections (LRTIs), with four requiring intensive care, which were disseminated Bacille Calmette-Guérin (BCG) disease, respiratory syncytial virus and SARS-CoV-2 infections, and influenza A(H1N1)pdm09 pneumonia. Chest computed tomography at 4 years showed bilateral consolidations without bronchiectasis. Annual autoimmune screening remained negative.Conclusion This case illustrates the burden caused by severe and diverse respiratory pathogenic infections in a child with trisomy 21 and a candidate BACH2 variant. Trisomy 21 alone plausibly explains much of the phenotype; an independent contribution from the BACH2 variant remains unproven pending functional and segregation studies. Clinical considerations supported by this case include the potential value of prevaccination immunological screening to prevent BCG disease, equitable access to viral prophylaxis, and early specialist engagement in refractory cases.
SN - 2296-858X
ER -